Mechanism of Action Trial of ColoAd1
NCT02053220
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Resectable Colon Cancer
Resectable Non-small Cell Lung Cancer
Resectable Bladder Cancer
Resectable Renal Cell Carcinoma
Interventions
BIOLOGICAL:
Colo-Ad1
Sponsor
Akamis Bio